Correlation Between Cadrenal Therapeutics, and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Biohaven Pharmaceutical.
Diversification Opportunities for Cadrenal Therapeutics, and Biohaven Pharmaceutical
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cadrenal and Biohaven is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Biohaven Pharmaceutical
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 2.21 times more return on investment than Biohaven Pharmaceutical. However, Cadrenal Therapeutics, is 2.21 times more volatile than Biohaven Pharmaceutical Holding. It trades about -0.04 of its potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about -0.11 per unit of risk. If you would invest 1,696 in Cadrenal Therapeutics, Common on September 1, 2024 and sell it today you would lose (177.00) from holding Cadrenal Therapeutics, Common or give up 10.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Biohaven Pharmaceutical |
Cadrenal Therapeutics, and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Biohaven Pharmaceutical
The main advantage of trading using opposite Cadrenal Therapeutics, and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.The idea behind Cadrenal Therapeutics, Common and Biohaven Pharmaceutical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |